CIMB, Vol. 45, Pages 4557-4573: Metabolic Silencing via Methionine-Based Amino Acid Restriction in Head and Neck Cancer

CIMB, Vol. 45, Pages 4557-4573: Metabolic Silencing via Methionine-Based Amino Acid Restriction in Head and Neck Cancer

Current Issues in Molecular Biology doi: 10.3390/cimb45060289

Authors: Anna Chiara Wünsch Elena Ries Sina Heinzelmann Andrea Frabschka Peter Christoph Wagner Theresa Rauch Corinna Koderer Mohamed El-Mesery Julian Manuel Volland Alexander Christian Kübler Stefan Hartmann Axel Seher

In recent years, various forms of caloric restriction (CR) and amino acid or protein restriction (AAR or PR) have shown not only success in preventing age-associated diseases, such as type II diabetes and cardiovascular diseases, but also potential for cancer therapy. These strategies not only reprogram metabolism to low-energy metabolism (LEM), which is disadvantageous for neoplastic cells, but also significantly inhibit proliferation. Head and neck squamous cell carcinoma (HNSCC) is one of the most common tumour types, with over 600,000 new cases diagnosed annually worldwide. With a 5-year survival rate of approximately 55%, the poor prognosis has not improved despite extensive research and new adjuvant therapies. Therefore, for the first time, we analysed the potential of methionine restriction (MetR) in selected HNSCC cell lines. We investigated the influence of MetR on cell proliferation and vitality, the compensation for MetR by homocysteine, the gene regulation of different amino acid transporters, and the influence of cisplatin on cell proliferation in different HNSCC cell lines.